Generic Sterile Injectables Market, By Drug Type (Monoclonal Antibodies, Cytokines, Insulin, Peptide Hormones, Vaccines, Immunoglobulin, Blood Factors, Antibiotics, and Others), By Therapeutic Application (Cancer, Diabetes, Cardiovascular Disease, Central Nervous System, Musculoskeletal System, and Others), By Distribution Channel (Hospitals, Drug Stores, and Retail Pharmacies), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis and Forecast till 2034

Report Code: PMI427720 | Publish Date: March 2024 | No. of Pages: 170

Global Generic Sterile Injectables Market Overview

Generic Sterile Injectables marketwas valued at US$ 117.6 Billion in 2024 and is projected to grow at a CAGR of 10.10% to reach US$ 282 Billion by 2034.

The generic sterile injectable deals with biologics which are used for the treatment of various drugs and has similar active ingredients. An injectable compounded medication is a sterile drug to be administered into the body using a syringe and needle or an I.V. administration set and needle device. Injectable should have limited endotoxin, must be sterile, and must meet labelled potency. Utilizing injectable medication that does not follow these specifications might lead to cause infections and other more severe complications. 

Impact of Covid-19 pandemic on market

Due to the outbreak of Covid-19 pandemic globally, countries are facing major shortages in the supply for diagnostic kits to test for the virus. Diagnostics virology entities are under immense pressure to offer reliable testing kits, and there is a surge in demand for in-vitro or point-of-care testing capacities by labs across the globe. The report will account for Covid19 as a key market contributor.

Global Generic Sterile Injectables Market Dynamics

Growing prevalence of cancer worldwide

Increasing prevalence of chronic illnesses particularly cancer across the world is expected to drive the demand for sterile injectable drugs in the coming years. In addition, growing number of drug manufacturers focusing on the production of drugs to treat cancer is also propelling growth of the target market. Further, rapid FDA approvals of sterile injectable drugs coupled with shortened approval times for new drug development in cancer cure is enhancing to dive drug supplies and is ultimately fueling demand in the global generic sterile injectables market.

High operational costs and discontinuation of products

Discontinuation of injectable drugs for cancer treatment and high operational costs are hampering the growth of revenue worldwide.  Sterile drugs needs complex kit for manufacturing. Every sterile drug needs proper sterilization and certification before production. This creates high operating costs and high debt levels. Furthermore, due to FDA regulations about maintaining a high degree of care in the manufacturing, packaging, storage and distribution of sterile injectable drugs, the cost of regulatory burden is also high. This factor is limiting revenue growth of the global generic sterile injectables market.

Access Crucial Insights at a Fraction of the Cost | Request Your Discount

Global Generic Sterile Injectables Market Segmentation

The generic sterile injectables market is segmented based on drug type, therapeutic application, distribution channel, and region.

On the basis of drug type, the global generic sterile injectables market is segmented into monoclonal antibodies, cytokines, insulin, peptide hormones, vaccines, immunoglobulin, blood factors, antibiotics, and others. On the basis of therapeutic application, the global market is classified into cancer, diabetes, cardiovascular disease, central nervous system, musculoskeletal system, and others. Based on distribution channel, the target market is segmented into hospitals, drug stores, and retail pharmacies.

Regional Insights:

On region the global generic sterile injectables market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America market is projected to lead the global market in terms of revenue and is predicted to maintain its position in the coming years. The governance can be attributed to favorable reimbursement policies, well-developed healthcare infrastructure, and presence of major players working in the countries in this region. Further, growing merger and acquisition activities among regional and international players is anticipated to boost growth of the market in this region. Asia Pacific market is anticipated to register faster growth due to growing government expenditure on healthcare sector and presence of prominent players operating in developing countries such as India and China in this region. The Latin America market is anticipated to register moderate growth, due to rising presence of major manufacturers in emerging economies such as Brazil and Argentina in this region.

Reduce costs by up to 30% with a custom report tailored to your specific needs | Request Customized Report

Report Scope:

Attribute

Details

Base year for estimation

2023

Forecast period

2024 – 2034

Market representation

Revenue in USD Million & CAGR from 2024 – 2034

Market Segmentation

By Drug type- Monoclonal Antibodies, Cytokines, Insulin, Peptide Hormones, Vaccines, Immunoglobulin, Blood Factors, Antibiotics, and Others

By Therapeutic application– Cancer, Diabetes, Cardiovascular Disease, Central Nervous System, Musculoskeletal System, and Others

By Distribution channel– Hospitals, Drug Stores, and Retail Pharmacies

Regional scope

North America - U.S., Canada

Europe - UK, Germany, Spain, France, Italy, Russia, Rest of Europe

Asia Pacific - Japan, India, China, South Korea, Australia, Rest of Asia-Pacific

Latin America - Brazil, Mexico, Argentina, Rest of Latin America

Middle East & Africa - South Africa, Saudi Arabia, UAE, Rest of Middle East & Africa

Report coverage

Revenue forecast, company share, competitive landscape, growth factors, and trends

Segments Covered in the Report:

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2019 to 2029. For the purpose of this study, has segmented the global generic sterile injectables market report based on drug type, therapeutic application, distribution channel, and region.

Global Generic Sterile Injectables Market, By Drug Type:

  • Monoclonal Antibodies
  • Cytokines
  • Insulin
  • Peptide Hormones
  • Vaccines
  • Immunoglobulin
  • Blood Factors
  • Antibiotics
  • Others

Global Generic Sterile Injectables Market, By Therapeutic Application:

  • Cancer
  • Diabetes
  • Cardiovascular Disease
  • Central Nervous System
  • Musculoskeletal System
  • Others

Global Generic Sterile Injectables Market, By Distribution Channel:

  • Hospitals
  • Drug Stores
  • Retail Pharmacies

Global Generic Sterile Injectables Market, By Region:

      • North America
          • U.S.
          • Canada
      • Europe
          • Germany
          • UK
          • France
          • Russia
          • Italy
          • Rest of Europe
      • Asia Pacific
          • China
          • India
          • Japan
          • South Korea
          • Rest of Asia Pacific
      • Latin America
          • Brazil
          • Mexico
          • Rest of Latin America
      • Middle East & Africa
          • GCC
          • Israel
          • South Africa
          • Rest of Middle East & Africa

Global Generic Sterile Injectables Market Key Players

The key players operating in the global generic sterile injectables market Sun Pharmaceutical Industries, Ltd., Aspen Pharmacare Holding, Ltd., Lupin Limited, Cipla Pharmaceuticals, Inc., Fresenius Kabi, AuroMedics Pharma LLC, Valeant Pharmaceuticals, Inc., Kay Pharma, CSC Pharmaceuticals, Inc., and Reddys Laboratories Limited. Prominent players working in the global generic sterile injectables market are struggling to acquire a dominant market position by means of acquiring small and large injectable firms in the market. Key players are concentrating on diverse global markets and are also focusing on expanding their manufacturing capacities to attain better economies of scale to enhance their geographic foothold in the global generic sterile injectables market. For instance, in April 2018, Endo International plc. Acquired Somerset Therapeutics, LLC, a New Jersey-based specialty pharmaceutical company that manufactures and markets sterile ophthalmic drugs and injectable for the U.S. market.

Global Generic Sterile Injectables Market Company Profile

  • Sun Pharmaceutical Industries, Ltd.
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Aspen Pharmacare Holding, Ltd.
  • Lupin Limited
  • Cipla Pharmaceuticals, Inc.
  • Fresenius Kabi
  • AuroMedics Pharma LLC
  • Valeant Pharmaceuticals, Inc.
  • Kay Pharma
  • CSC Pharmaceuticals, Inc.
  • Reddys Laboratories Limited

 “*” marked represents similar segmentation in other categories in the respective section

Global Generic Sterile Injectables Market Table of Contents

  • Research Objective and Assumption
    • Preface
    • Research Objectives
    • Study Scope
    • Years Considered for the study
    • Assumptions
    • Abbreviations
  • Research Methodology
    • Research data
    • Primary Data
      • Primary Interviews
      • Primary Breakdown
      • Key data from Primary Sources
      • Key Thickness Insights
    • Secondary Data
      • Major Secondary Sources
      • Secondary Sources
    • Market Estimation
    • Top-Down Approach
      • Approach for estimating Market Share by Top-Down Analysis (Supply Side)
    • Bottom-Up Approach
      • Approach for estimating market share by Bottom-up Analysis (Demand Side)
    • Market Breakdown and Data Triangulation
    • Research Assumptions
  • Market Purview
    • Executive Summary
    • Key Findings—Global Outlook for Generic Sterile Injectables Strategies
      • Key Questions this Study will Answer
      • Market Snippet, By Drug Type
      • Market Snippet, By Therapeutic Application
      • Market Snippet, By Distribution Channel
      • Market Snippet, By Region
    • Opportunity Map Analysis
    • Executive Summary—3 Big Predictions
  • Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
      • Market Trends
    • DR Impact Analysis
    • PEST Analysis
    • Porter’s Five Forces Analysis
    • Opportunity Orbit
    • Market Investment Feasibility Index
    • Macroeconomic Factor Analysis
  • Global Generic Sterile Injectables Market, By Drug Type, 2020 – 2029, (US$ Mn)
    • Overview
      • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2029
      • Y-o-Y Growth Analysis (%), 2020 – 2029
      • Segment Trends
    • Monoclonal Antibodies
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2029
    • Cytokines
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2029
    • Insulin
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2029
    • Peptide Hormones
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2029
    • Vaccines
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2029
    • Immunoglobulin
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2029
    • Blood Factors
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2029
    • Antibiotics
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2029
    • Others
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2029
  • Global Generic Sterile Injectables Market, By Therapeutic Application, 2020 – 2029, (US$ Mn)
    • Overview
      • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2029
      • Y-o-Y Growth Analysis (%), 2020 – 2029
      • Segment Trends
    • Cancer
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2029
    • Diabetes
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2029
    • Cardiovascular Disease
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2029
    • Central Nervous System
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2029
    • Musculoskeletal System
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2029
    • Others
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2029
  • Global Generic Sterile Injectables Market, By Distribution Channel, 2020 – 2029, (US$ Mn)
    • Overview
      • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2029
      • Y-o-Y Growth Analysis (%), 2020 – 2029
      • Segment Trends
    • Hospitals
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2029
    • Drug Stores
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2029
    • Retail Pharmacies
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2029
  • Global Generic Sterile Injectables Market, By Region, 2020 – 2029, (US$ Mn)
    • Overview
      • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2029
      • Y-o-Y Growth Analysis (%), 2020 – 2029
      • Regional Trends
    • North America
      • Market Size and Forecast (US$ Mn), By Drug Type, 2020 – 2029
      • Market Size and Forecast (US$ Mn), By Therapeutic Application, 2020 – 2029
      • Market Size and Forecast (US$ Mn), By Distribution Channel, 2020 – 2029
      • Market Size and Forecast (US$ Mn), By Country, 2020 – 2029
        • U.S.
        • Canada
    • Europe
      • Market Size and Forecast (US$ Mn), By Drug Type, 2020 – 2029
      • Market Size and Forecast (US$ Mn), By Therapeutic Application, 2020 – 2029
      • Market Size and Forecast (US$ Mn), By Distribution Channel, 2020 – 2029
      • Market Size and Forecast (US$ Mn), By Country, 2020 – 2029
        • Germany
        • UK
        • France
        • Russia
        • Italy
        • Rest of Europe
    • Asia Pacific
      • Market Size and Forecast (US$ Mn), By Drug Type, 2020 – 2029
      • Market Size and Forecast (US$ Mn), By Therapeutic Application, 2020 – 2029
      • Market Size and Forecast (US$ Mn), By Distribution Channel, 2020 – 2029
      • Market Size and Forecast (US$ Mn), By Country, 2020 – 2029
        • China
        • India
        • Japan
        • South Korea
        • Rest of Asia Pacific
    • Latin America
      • Market Size and Forecast (US$ Mn), By Drug Type, 2020 – 2029
      • Market Size and Forecast (US$ Mn), By Therapeutic Application, 2020 – 2029
      • Market Size and Forecast (US$ Mn), By Distribution Channel, 2020 – 2029
      • Market Size  and Forecast (US$ Mn), By Country, 2020 – 2029
        • Brazil
        • Mexico
        • Rest of Latin America
    • Middle East & Africa
      • Market Size and Forecast (US$ Mn), By Drug Type, 2020 – 2029
      • Market Size and Forecast (US$ Mn), By Therapeutic Application, 2020 – 2029
      • Market Size and Forecast (US$ Mn), By Distribution Channel, 2020 – 2029
      • Market Size and Forecast (US$ Mn), By Country, 2020 – 2029
        • GCC
        • Israel
        • South Africa
        • Rest of Middle East
  • Competitive Landscape
    • Heat Map Analysis
    • Market Presence and Specificity Analysis
  • Company Profiles
      • Sun Pharmaceutical Industries, Ltd.
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Business Strategies
      • Aspen Pharmacare Holding, Ltd.
      • Lupin Limited
      • Cipla Pharmaceuticals, Inc.
      • Fresenius Kabi
      • AuroMedics Pharma LLC
      • Valeant Pharmaceuticals, Inc.
      • Kay Pharma
      • CSC Pharmaceuticals, Inc.
      • Reddys Laboratories Limited
  • The Last Word
    • Future Impact
    • About Us
    • Contact

FAQs

The global generic sterile injectables market is segmented based on drug type, therapeutic application, distribution channel, and region.

Increasing prevalence of chronic illnesses particularly cancer across the world is the major factor driving the growth of the global market

North America market is projected to lead the global market in terms of revenue and is predicted to maintain its position in the coming years. The governance can be attributed to favorable reimbursement policies, well-developed healthcare infrastructure, and the presence of major players working in the countries in this region.

Prominent players working in the global generic sterile injectables market are struggling to acquire a dominant market position by means of acquiring small and large injectable firms in the market. Key players are concentrating on diverse global markets and are also focusing on expanding their manufacturing capacities to attain better economies of scale to enhance their geographic foothold in the global generic sterile injectables market.